Observational Study
Copyright ©The Author(s) 2022.
World J Diabetes. Nov 15, 2022; 13(11): 986-1000
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.986
Table 1 Univariate analysis of risk factors for diabetic retinopathy or proliferative diabetic retinopathy
Variable
WDR group (n = 826)
DR group (n = 828)
NPDR group (n = 403)
PDR group (n = 425)
P value1
P value2
Age (yr)53.9 ± 10.354.9 ± 10.756.2 ± 10.953.6 ± 10.30.056< 0.001
Sex (male/female)487/339424/404238/165186/2390.002< 0.001
Diabetes duration (yr)6.9 ± 5.211.2 ± 6.810.9 ± 7.111.4 ± 6.4< 0.0010.221
Height (cm)165.2 ± 8.3162.5 ± 8.3164.2 ± 8.5160.8 ± 7.8< 0.001< 0.001
Weight (kg)68.1 ± 11.764.2 ± 11.365.7 ± 11.562.8 ± 10.9< 0.001< 0.001
BMI (kg/m2)24.9 ± 3.324.3 ± 3.424.3 ± 3.324.2 ± 3.5< 0.0010.880
Waist circumference (cm)90.8 ± 9.589.9 ± 10.090.2 ± 9.789.6 ± 10.30.0600.399
Hip circumference (cm)97.6 ± 7.695.9 ± 7.496.4 ± 7.295.4 ± 7.6< 0.0010.046
WHR1.0 ± 0.50.9 ± 0.10.9 ± 0.10.9 ± 0.10.2840.092
Standing SBP (mmHg)129.0 ± 16.9136.4 ± 22.9135.9 ± 22.6136.9 ± 23.2< 0.0010.517
Standing DBP (mmHg)83.4 ± 11.683.8 ± 13.483.5 ± 13.084.0 ± 13.70.5010.578
Supine SBP (mmHg)130.1 ± 16.3141.0 ± 21.3139.4 ± 20.6142.4 ± 22.0< 0.0010.045
Supine DBP (mmHg)82.6 ± 11.285.0 ± 12.383.9±12.086.1 ± 12.4< 0.0010.012
Glu0 (mmol/L)9.4 ± 3.39.9 ± 3.710.0 ± 3.79.8 ± 3.70.0080.647
HbA1c (%)9.1 ± 2.59.8 ± 2.49.9 ± 2.59.7 ± 2.3< 0.0010.402
Chol (mmol/L)4.4 ± 1.55.0 ± 1.54.8 ± 1.55.1 ± 1.4< 0.0010.013
Trig (mmol/L)2.8 ± 2.32.6 ± 2.42.6 ± 2.52.6 ± 2.40.0330.856
HDL-C (mmol/L)1.1 ± 0.31.1 ± 0.31.1 ± 0.31.1 ± 0.40.0570.095
LDL-C (mmol/L)2.9 ± 0.93.0 ± 1.02.9 ± 1.03.1 ± 1.10.1010.004
BUN (μmol/L)5.1 ± 1.76.6 ± 2.86.4 ± 2.86.8 ± 2.8< 0.0010.021
UA (μmol/L)347.6 ± 103.4359.4 ± 102.0355.4 ± 106.4363.2 ± 97.60.0190.270
Scr (μmol/L)69.8 ± 28.390.0 ± 61.886.0 ± 64.193.9 ± 59.4< 0.0010.068
eGFR (mL/min)116.9 ± 37.398.3 ± 42.4103.5 ± 40.993.3 ± 43.2< 0.0010.001